Simple Method to Predict Insulin Resistance in Children Aged 6-12 Years by Using Machine Learning

Qian Zhang1, Nai-Jun Wan1

  • 1Department of Pediatrics, Beijing Jishuitan Hospital, Beijing, People's Republic of China.

Insights

A new machine learning model effectively predicts childhood insulin resistance (IR), a key factor for future diabetes and cardiovascular disease. This simple tool aids pediatricians in early identification and intervention for at-risk children.

Area of Science:

  • Pediatric Endocrinology
  • Biostatistics
  • Machine Learning in Healthcare

Background:

  • Childhood insulin resistance (IR) is a growing concern, potentially leading to increased rates of diabetes and cardiovascular disease.
  • Early identification of IR in children is crucial for timely intervention and preventing long-term health complications.
  • Primary care practitioners require accessible tools to screen for pediatric IR.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting insulin resistance in children aged 6-12 years.
  • To identify key clinical features predictive of IR in the pediatric population.
  • To establish a simple, cost-effective method for IR screening in primary care settings.

Main Methods:

  • Utilized data from 503 children (aged 6-12), defining IR using HOMA-IR > 3.0.
  • Applied data preprocessing techniques including imputation and oversampling, followed by recursive feature elimination.
  • Trained and evaluated five machine learning models (LR, SVM, RF, XGBoost, CatBoost) on an external dataset of 133 children.

Main Results:

  • The XGBoost model, utilizing 14 selected features including glucose, waist circumference, and age, demonstrated the highest performance.
  • XGBoost achieved an Area Under the Curve (AUC) of 0.85, with strong accuracy, sensitivity, precision, and F1 scores.
  • XGBoost exhibited superior specificity (0.79) compared to other models, making it the optimal choice for IR prediction.

Conclusions:

  • The developed XGBoost model accurately predicts IR in children aged 6-12.
  • This model offers a clinically applicable, simple, and inexpensive method for pediatric IR screening.
  • Early identification via this model can facilitate timely interventions, mitigating risks of future diabetes and cardiovascular disease.
Abstract